Patent Assignment
Reel/Frame 019116/0508
Merger
Recorded: 2007-04-05
Pages: 5
Assignor
SYNTEX (U.S.A.) INC.
Executed: 2000-05-13
Assignee
SYNTEX (U.S.A.) LLC
3401 HILLVIEW AVENUE, PALO ALTO, CALIFORNIA, 94303
Covered Property
(1)
Nicardipine Pharmaceutical Composition for Parenteral Administration
Patent:
5,164,405 →
Application:
07/600,277 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 14, 2003
From: ROCHE HOLDINGS, INC.
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 013653/0418 →
Assignment of Assignor's Interest
Jan 14, 2003
From: SYNTEX (U.S.A.) LLC (INTO WHICH SYNTEX (U.S.A.) INC. WAS MERGED)
To: ROCHE HOLDINGS, INC.
Reel/Frame 013653/0444 →
Assignment of Assignor's Interest
Nov 16, 2006
From: HOFFMANN-LA ROCHE INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 018524/0632 →
Assignment of Assignor's Interest
Apr 5, 2007
From: MACFARLANE, CALUM B.; SELKIRK, ALISTAIR B.; DEY, MICHAEL J.
To: SYNTEX (U.S.A.) INC.
Reel/Frame 019116/0504 →
Assignment of Assignor's Interest
Jul 18, 2008
From: PDL BIOPHARMA, INC.
To: EKR THERAPEUTICS, INC.
Reel/Frame 021253/0306 →
Security Agreement
Dec 15, 2008
From: EKR THERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021976/0780 →